25 XP   0   0   10

Beijing SL Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Beijing SL Pharmaceutical Co Ltd together

PenkeI guess you are interested in Beijing SL Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Beijing SL Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Beijing SL Pharmaceutical Co Ltd

I send you an email if I find something interesting about Beijing SL Pharmaceutical Co Ltd.

Quick analysis of Beijing SL Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Beijing SL Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
75.0%

What is your share worth?

Current worth
¥5.54
Expected worth in 1 year
¥5.77
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.53
Return On Investment
6.1%

For what price can you sell your share?

Current Price per Share
¥8.62
Expected price per share
¥7.05 - ¥9.76
How sure are you?
50%

1. Valuation of Beijing SL Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.62

Intrinsic Value Per Share

¥-0.64 - ¥2.73

Total Value Per Share

¥4.90 - ¥8.27

2. Growth of Beijing SL Pharmaceutical Co Ltd (5 min.)




Is Beijing SL Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$786.1m$744.4m$33.9m4.4%

How much money is Beijing SL Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$10.8m$7.8m$2.9m27.4%
Net Profit Margin26.7%20.7%--

How much money comes from the company's main activities?

3. Financial Health of Beijing SL Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Beijing SL Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Beijing SL Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Beijing SL Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Beijing SL Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Beijing SL Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Beijing SL Pharmaceutical Co Ltd is ¥8.62. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Beijing SL Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Beijing SL Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.54. Based on the TTM, the Book Value Change Per Share is ¥0.06 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Beijing SL Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.020.2%0.010.1%0.010.2%0.020.2%
Usd Book Value Change Per Share0.000.0%0.010.1%0.000.1%0.010.1%0.010.1%
Usd Dividend Per Share0.000.0%0.010.1%0.010.1%0.020.2%0.010.2%
Usd Total Gains Per Share0.000.0%0.020.2%0.020.2%0.020.3%0.020.3%
Usd Price Per Share1.71-1.36-1.36-1.77-3.38-
Price to Earnings Ratio7,871.29-1,978.80--45.16-399.35-233.00-
Price-to-Total Gains Ratio263,118.61-65,827.18-462.86-13,331.78-6,777.70-
Price to Book Ratio2.23-1.79-1.88-2.61-6.57-
Price-to-Total Gains Ratio263,118.61-65,827.18-462.86-13,331.78-6,777.70-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.190422
Number of shares840
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.02
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.020.02
Gains per Quarter (840 shares)15.2720.94
Gains per Year (840 shares)61.0683.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1352651562774
2705311211355158
31047917316982242
4139105234226109326
5174131295282136410
6209158356339164494
7244184417395191578
8278210478452218662
9313236539508246746
10348263600565273830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%38.02.00.095.0%76.02.00.097.4%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%17.03.00.085.0%34.06.00.085.0%71.07.00.091.0%
Dividend per Share3.00.01.075.0%11.00.01.091.7%19.00.01.095.0%30.00.010.075.0%57.00.021.073.1%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%77.01.00.098.7%

Fundamentals of Beijing SL Pharmaceutical Co Ltd

About Beijing SL Pharmaceutical Co Ltd

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide capsules; docetaxel; paclitaxel; recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; liraglutide; insulin aspart 30; insulin aspart 50; insulin aspart; recombinant human follitropin(rh-fsh); ciclosporin; mycophenolate mofetil dispersible; voriconazole; ornidazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; ademetionine 1,4-butanedisulfonate; glutathione; rivaroxaban; enoxaparin sodium; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; risedronate sodium; loratadine dispersible; somatostatin; octreotide acetate; calcitonin; paracetamol and tramadol hydrochloride; and etodolac. It also offers active pharmaceutical ingredients. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is headquartered in Beijing, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-14 12:29:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Beijing SL Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Beijing SL Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.2% means that ¥0.00 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 0.2%. The company is not making a profit/loss.
  • The TTM is 26.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ0.2%TTM26.7%-26.5%
TTM26.7%YOY20.7%+6.0%
TTM26.7%5Y27.9%-1.2%
5Y27.9%10Y37.5%-9.6%
1.1.2. Return on Assets

Shows how efficient Beijing SL Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Assets means that Beijing SL Pharmaceutical Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.0%TTM1.3%-1.3%
TTM1.3%YOY1.0%+0.3%
TTM1.3%5Y1.7%-0.4%
5Y1.7%10Y2.8%-1.1%
1.1.3. Return on Equity

Shows how efficient Beijing SL Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Beijing SL Pharmaceutical Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.0%TTM1.4%-1.4%
TTM1.4%YOY1.1%+0.3%
TTM1.4%5Y1.8%-0.4%
5Y1.8%10Y3.0%-1.2%

1.2. Operating Efficiency of Beijing SL Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Beijing SL Pharmaceutical Co Ltd is operating .

  • Measures how much profit Beijing SL Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 14.3% means the company generated ¥0.14  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 14.3%. The company is operating less efficient.
  • The TTM is 20.0%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ14.3%TTM20.0%-5.7%
TTM20.0%YOY15.7%+4.3%
TTM20.0%5Y19.9%+0.1%
5Y19.9%10Y11.7%+8.3%
1.2.2. Operating Ratio

Measures how efficient Beijing SL Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.30 means that the operating costs are ¥1.30 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 1.304. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.005. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.304TTM1.005+0.300
TTM1.005YOY0.967+0.037
TTM1.0055Y0.978+0.027
5Y0.97810Y0.658+0.320

1.3. Liquidity of Beijing SL Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Beijing SL Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 7.85 means the company has ¥7.85 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 7.847. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.356. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.847TTM7.356+0.491
TTM7.356YOY7.451-0.095
TTM7.3565Y7.380-0.024
5Y7.38010Y4.295+3.084
1.3.2. Quick Ratio

Measures if Beijing SL Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.32 means the company can pay off ¥1.32 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 1.323. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.353. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.323TTM1.353-0.030
TTM1.353YOY1.568-0.216
TTM1.3535Y1.796-0.443
5Y1.79610Y3.872-2.076

1.4. Solvency of Beijing SL Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Beijing SL Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.06 means that Beijing SL Pharmaceutical Co Ltd assets are financed with 6.2% credit (debt) and the remaining percentage (100% - 6.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 0.062. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.065. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.065-0.003
TTM0.065YOY0.072-0.007
TTM0.0655Y0.075-0.009
5Y0.07510Y0.058+0.016
1.4.2. Debt to Equity Ratio

Measures if Beijing SL Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 6.6% means that company has ¥0.07 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The MRQ is 0.066. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.070. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.066TTM0.070-0.004
TTM0.070YOY0.078-0.008
TTM0.0705Y0.081-0.011
5Y0.08110Y0.063+0.018

2. Market Valuation of Beijing SL Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Beijing SL Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Beijing SL Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 7,871.29 means the investor is paying ¥7,871.29 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The EOD is 5,480.658. Based on the earnings, the company is expensive. -2
  • The MRQ is 7,871.293. Based on the earnings, the company is expensive. -2
  • The TTM is 1,978.797. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5,480.658MRQ7,871.293-2,390.635
MRQ7,871.293TTM1,978.797+5,892.496
TTM1,978.797YOY-45.161+2,023.959
TTM1,978.7975Y399.352+1,579.446
5Y399.35210Y233.004+166.347
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The EOD is -325.114. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -466.927. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -72.631. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-325.114MRQ-466.927+141.813
MRQ-466.927TTM-72.631-394.296
TTM-72.631YOY40.787-113.419
TTM-72.6315Y-120.061+47.430
5Y-120.06110Y-17.577-102.483
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Beijing SL Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Beijing SL Pharmaceutical Co Ltd:

  • The EOD is 1.556. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.234. Based on the equity, the company is underpriced. +1
  • The TTM is 1.788. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.556MRQ2.234-0.679
MRQ2.234TTM1.788+0.446
TTM1.788YOY1.881-0.093
TTM1.7885Y2.612-0.824
5Y2.61210Y6.573-3.960
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Beijing SL Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.057-100%0.034-100%0.059-100%0.079-100%
Book Value Per Share--5.5415.487+1%5.247+6%5.034+10%4.314+28%
Current Ratio--7.8477.356+7%7.451+5%7.380+6%4.295+83%
Debt To Asset Ratio--0.0620.065-5%0.072-14%0.075-17%0.058+6%
Debt To Equity Ratio--0.0660.070-6%0.078-15%0.081-18%0.063+5%
Dividend Per Share---0.075-100%0.075-100%0.122-100%0.096-100%
Eps--0.0000.126-100%0.055-99%0.101-100%0.122-100%
Free Cash Flow Per Share---0.0070.034-120%0.061-111%0.055-112%0.104-106%
Free Cash Flow To Equity Per Share---0.007-0.041+522%-0.015+122%-0.025+282%0.055-112%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.726--------
Intrinsic Value_10Y_min---0.641--------
Intrinsic Value_1Y_max--0.394--------
Intrinsic Value_1Y_min--0.165--------
Intrinsic Value_3Y_max--1.093--------
Intrinsic Value_3Y_min--0.300--------
Intrinsic Value_5Y_max--1.680--------
Intrinsic Value_5Y_min--0.219--------
Market Cap8855757137.920-44%12718593198.08010093713907.200+26%10132239532.800+26%13192371132.971-4%25115415022.335-49%
Net Profit Margin--0.0020.267-99%0.207-99%0.279-99%0.375-99%
Operating Margin--0.1430.200-28%0.157-9%0.199-28%0.117+23%
Operating Ratio--1.3041.005+30%0.967+35%0.978+33%0.658+98%
Pb Ratio1.556-44%2.2341.788+25%1.881+19%2.612-14%6.573-66%
Pe Ratio5480.658-44%7871.2931978.797+298%-45.161+101%399.352+1871%233.004+3278%
Price Per Share8.620-44%12.3809.825+26%9.863+26%12.841-4%24.446-49%
Price To Free Cash Flow Ratio-325.114+30%-466.927-72.631-84%40.787-1245%-120.061-74%-17.577-96%
Price To Total Gains Ratio183205.365-44%263118.61165827.185+300%462.860+56746%13331.778+1874%6777.697+3782%
Quick Ratio--1.3231.353-2%1.568-16%1.796-26%3.872-66%
Return On Assets--0.0000.013-99%0.010-99%0.017-100%0.028-100%
Return On Equity--0.0000.014-99%0.011-99%0.018-100%0.030-100%
Total Gains Per Share--0.0000.132-100%0.109-100%0.180-100%0.175-100%
Usd Book Value--786166134.387778445476.500+1%744489480.663+6%714174370.308+10%612092096.758+28%
Usd Book Value Change Per Share--0.0000.008-100%0.005-100%0.008-100%0.011-100%
Usd Book Value Per Share--0.7650.758+1%0.725+6%0.695+10%0.596+28%
Usd Dividend Per Share---0.010-100%0.010-100%0.017-100%0.013-100%
Usd Eps--0.0000.017-100%0.008-99%0.014-100%0.017-100%
Usd Free Cash Flow---940424.5004789865.492-120%8697431.275-111%7761941.789-112%14696561.569-106%
Usd Free Cash Flow Per Share---0.0010.005-120%0.008-111%0.008-112%0.014-106%
Usd Free Cash Flow To Equity Per Share---0.001-0.006+522%-0.002+122%-0.004+282%0.008-112%
Usd Market Cap1222980060.747-44%1756437720.6551393941890.584+26%1399262279.480+26%1821866453.463-4%3468438814.584-49%
Usd Price Per Share1.190-44%1.7101.357+26%1.362+26%1.773-4%3.376-49%
Usd Profit--55786.13410841677.426-99%7869878.970-99%12904762.782-100%16549281.409-100%
Usd Revenue--26670274.98134518909.776-23%38958064.764-32%46957373.585-43%46046056.245-42%
Usd Total Gains Per Share--0.0000.018-100%0.015-100%0.025-100%0.024-100%
 EOD+3 -5MRQTTM+13 -22YOY+13 -225Y+12 -2310Y+9 -26

3.2. Fundamental Score

Let's check the fundamental score of Beijing SL Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155,480.658
Price to Book Ratio (EOD)Between0-11.556
Net Profit Margin (MRQ)Greater than00.002
Operating Margin (MRQ)Greater than00.143
Quick Ratio (MRQ)Greater than11.323
Current Ratio (MRQ)Greater than17.847
Debt to Asset Ratio (MRQ)Less than10.062
Debt to Equity Ratio (MRQ)Less than10.066
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Beijing SL Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.293
Ma 20Greater thanMa 508.481
Ma 50Greater thanMa 1008.853
Ma 100Greater thanMa 2009.293
OpenGreater thanClose8.610
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Income before Tax  76,761-67,3259,436221,412230,848-111,322119,526-125,263-5,737
Tax Provision  5,16810,78615,95413,21329,168-24,1405,027-10,813-5,785



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,067,610
Total Liabilities374,879
Total Stockholder Equity5,682,915
 As reported
Total Liabilities 374,879
Total Stockholder Equity+ 5,682,915
Total Assets = 6,067,610

Assets

Total Assets6,067,610
Total Current Assets2,048,073
Long-term Assets4,019,538
Total Current Assets
Cash And Cash Equivalents 735,398
Short-term Investments 136,445
Net Receivables 208,842
Inventory 149,612
Other Current Assets 817,776
Total Current Assets  (as reported)2,048,073
Total Current Assets  (calculated)2,048,073
+/- 0
Long-term Assets
Property Plant Equipment 499,235
Intangible Assets 1,077,307
Other Assets 1,348,253
Long-term Assets  (as reported)4,019,538
Long-term Assets  (calculated)2,924,796
+/- 1,094,742

Liabilities & Shareholders' Equity

Total Current Liabilities261,015
Long-term Liabilities113,864
Total Stockholder Equity5,682,915
Total Current Liabilities
Accounts payable 168,242
Other Current Liabilities 64,891
Total Current Liabilities  (as reported)261,015
Total Current Liabilities  (calculated)233,133
+/- 27,882
Long-term Liabilities
Other Liabilities 113,864
Long-term Liabilities  (as reported)113,864
Long-term Liabilities  (calculated)113,864
+/- 0
Total Stockholder Equity
Common Stock1,027,350
Retained Earnings 4,611,052
Other Stockholders Equity 667
Total Stockholder Equity (as reported)5,682,915
Total Stockholder Equity (calculated)5,639,069
+/- 43,847
Other
Capital Stock1,027,350
Common Stock Shares Outstanding 1,027,350
Net Invested Capital 5,682,915
Net Tangible Assets 5,039,845
Net Working Capital 1,787,058
Property Plant and Equipment Gross 499,235



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302003-12-312002-12-312001-12-31
> Total Assets 
77,130
102,835
151,831
147,504
367,174
389,826
397,433
390,021
400,646
405,908
419,986
424,683
442,718
461,606
479,220
507,547
538,184
586,635
626,221
677,635
748,933
788,516
848,451
886,602
964,254
1,019,806
1,088,928
1,124,567
1,188,230
1,248,573
1,326,457
1,558,254
1,683,773
1,736,141
1,857,593
1,998,576
2,059,783
2,216,702
2,305,115
2,345,530
2,503,317
2,712,099
2,870,187
3,054,762
3,136,298
3,319,069
3,513,062
3,660,140
3,634,465
3,761,619
3,910,082
3,995,228
3,967,983
4,081,272
4,213,774
4,315,080
4,360,429
4,585,062
4,759,509
4,582,621
4,762,215
4,988,274
5,190,091
5,314,304
5,248,932
5,224,966
5,307,454
5,408,339
5,323,528
5,394,829
5,515,951
5,713,074
5,730,883
5,760,464
5,797,919
5,797,250
5,886,267
5,875,840
6,089,175
6,086,827
6,067,610
6,067,6106,086,8276,089,1755,875,8405,886,2675,797,2505,797,9195,760,4645,730,8835,713,0745,515,9515,394,8295,323,5285,408,3395,307,4545,224,9665,248,9325,314,3045,190,0914,988,2744,762,2154,582,6214,759,5094,585,0624,360,4294,315,0804,213,7744,081,2723,967,9833,995,2283,910,0823,761,6193,634,4653,660,1403,513,0623,319,0693,136,2983,054,7622,870,1872,712,0992,503,3172,345,5302,305,1152,216,7022,059,7831,998,5761,857,5931,736,1411,683,7731,558,2541,326,4571,248,5731,188,2301,124,5671,088,9281,019,806964,254886,602848,451788,516748,933677,635626,221586,635538,184507,547479,220461,606442,718424,683419,986405,908400,646390,021397,433389,826367,174147,504151,831102,83577,130
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,014,533
2,912,599
2,803,158
2,990,001
3,100,573
3,028,427
2,865,342
2,485,104
2,423,273
2,173,369
2,207,337
2,262,116
2,366,159
2,263,941
2,297,730
2,368,782
2,329,363
2,376,344
1,997,674
2,113,468
2,039,044
2,048,073
2,048,0732,039,0442,113,4681,997,6742,376,3442,329,3632,368,7822,297,7302,263,9412,366,1592,262,1162,207,3372,173,3692,423,2732,485,1042,865,3423,028,4273,100,5732,990,0012,803,1582,912,5993,014,53300000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,319,500
1,178,086
1,166,198
1,309,681
1,305,855
1,189,875
1,260,864
802,854
933,238
527,581
663,480
812,366
823,186
757,287
827,837
859,911
842,033
914,681
595,038
702,888
704,902
735,398
735,398704,902702,888595,038914,681842,033859,911827,837757,287823,186812,366663,480527,581933,238802,8541,260,8641,189,8751,305,8551,309,6811,166,1981,178,0861,319,50000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
519,121
0
506,031
39,045
33,501
32,227
140,450
144,198
146,944
167,787
173,811
151,975
194,138
169,819
162,364
169,229
158,407
140,844
144,906
141,275
139,376
136,445
136,445139,376141,275144,906140,844158,407169,229162,364169,819194,138151,975173,811167,787146,944144,198140,45032,22733,50139,045506,0310519,12100000000000000000000000000000000000000000000000000000000000
       Net Receivables 
12,726
16,698
19,406
23,689
20,703
24,656
25,294
27,143
26,591
24,815
23,424
31,387
39,997
30,776
28,924
36,773
33,165
41,665
35,802
55,810
82,187
71,066
83,271
89,177
113,738
122,921
122,255
132,761
135,046
144,084
160,717
466,910
269,340
277,196
287,109
271,036
312,793
418,989
435,859
459,395
502,095
554,751
591,773
652,736
676,007
839,235
713,164
716,834
700,073
793,472
780,630
779,749
723,068
726,559
715,073
650,006
669,122
746,935
741,402
711,228
736,738
723,128
694,108
655,124
640,657
644,491
543,532
548,200
494,509
468,982
428,558
399,297
385,158
379,162
346,916
319,993
296,768
252,570
263,797
224,282
208,842
208,842224,282263,797252,570296,768319,993346,916379,162385,158399,297428,558468,982494,509548,200543,532644,491640,657655,124694,108723,128736,738711,228741,402746,935669,122650,006715,073726,559723,068779,749780,630793,472700,073716,834713,164839,235676,007652,736591,773554,751502,095459,395435,859418,989312,793271,036287,109277,196269,340466,910160,717144,084135,046132,761122,255122,921113,73889,17783,27171,06682,18755,81035,80241,66533,16536,77328,92430,77639,99731,38723,42424,81526,59127,14325,29424,65620,70323,68919,40616,69812,726
       Inventory 
1,088
3,894
9,162
7,629
5,312
7,675
7,292
6,347
13,999
8,158
12,722
4,281
5,274
7,530
7,687
6,427
7,949
6,133
7,480
8,366
7,735
8,614
8,490
13,306
14,469
24,375
26,686
41,338
47,353
29,523
40,465
56,637
73,645
64,557
73,977
67,040
79,620
57,050
98,550
173,148
175,617
110,891
111,841
98,967
110,145
112,212
98,987
94,056
112,458
129,666
163,190
184,655
196,512
198,216
209,068
222,706
274,016
275,696
303,250
280,449
302,419
251,268
220,437
150,883
137,627
108,346
163,199
118,258
127,649
112,032
111,460
129,601
124,652
124,832
148,198
151,222
144,384
136,818
184,669
159,879
149,612
149,612159,879184,669136,818144,384151,222148,198124,832124,652129,601111,460112,032127,649118,258163,199108,346137,627150,883220,437251,268302,419280,449303,250275,696274,016222,706209,068198,216196,512184,655163,190129,666112,45894,05698,987112,212110,14598,967111,841110,891175,617173,14898,55057,05079,62067,04073,97764,55773,64556,63740,46529,52347,35341,33826,68624,37514,46913,3068,4908,6147,7358,3667,4806,1337,9496,4277,6877,5305,2744,28112,7228,15813,9996,3477,2927,6755,3127,6299,1623,8941,088
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,200,089
2,213,731
2,220,505
2,359,624
2,822,351
2,985,066
3,150,159
3,187,492
3,253,835
3,346,915
3,466,942
3,462,734
3,429,137
3,467,887
3,509,923
3,878,166
3,975,706
4,047,783
4,019,538
4,019,5384,047,7833,975,7063,878,1663,509,9233,467,8873,429,1373,462,7343,466,9423,346,9153,253,8353,187,4923,150,1592,985,0662,822,3512,359,6242,220,5052,213,7312,200,08900000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
27,762
46,222
46,790
44,680
45,262
73,248
77,677
87,297
89,801
98,592
99,125
103,202
98,594
103,550
91,852
101,201
91,717
120,338
108,540
116,619
104,975
112,873
103,795
119,502
101,463
118,364
101,065
119,196
103,240
198,413
181,425
198,024
183,816
214,334
206,925
238,653
243,374
347,885
337,834
350,332
342,561
423,269
356,780
369,510
380,265
414,145
405,542
415,354
414,844
459,754
469,162
475,858
475,304
481,067
493,535
499,142
522,296
556,315
547,240
546,810
548,610
559,344
557,967
558,657
574,392
587,959
580,250
577,673
582,793
589,155
592,996
572,819
563,630
604,012
595,152
594,010
584,872
527,304
518,383
509,936
499,235
499,235509,936518,383527,304584,872594,010595,152604,012563,630572,819592,996589,155582,793577,673580,250587,959574,392558,657557,967559,344548,610546,810547,240556,315522,296499,142493,535481,067475,304475,858469,162459,754414,844415,354405,542414,145380,265369,510356,780423,269342,561350,332337,834347,885243,374238,653206,925214,334183,816198,024181,425198,413103,240119,196101,065118,364101,463119,502103,795112,873104,975116,619108,540120,33891,717101,20191,852103,55098,594103,20299,12598,59289,80187,29777,67773,24845,26244,68046,79046,22227,762
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
207,063
446,373
520,020
571,528
594,983
593,471
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000593,471594,983571,528520,020446,373207,06300000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
10,056
11,452
18,576
17,509
25,277
18,911
18,310
13,198
17,081
13,706
17,522
12,471
16,235
11,237
21,191
10,003
22,094
8,768
21,689
7,574
25,836
10,057
30,580
18,642
52,111
17,651
57,927
20,310
63,134
21,076
67,434
19,379
70,295
18,356
81,518
16,625
101,250
14,988
114,743
13,566
128,279
12,259
75,199
74,282
75,367
78,106
77,038
75,975
74,942
85,482
82,022
80,798
80,019
105,969
104,417
102,864
101,312
225,769
224,948
220,122
215,321
517,633
719,912
607,394
696,018
641,178
632,372
634,815
690,616
713,677
725,930
776,426
830,554
872,816
876,293
917,533
926,725
978,507
994,677
1,069,172
1,077,307
1,077,3071,069,172994,677978,507926,725917,533876,293872,816830,554776,426725,930713,677690,616634,815632,372641,178696,018607,394719,912517,633215,321220,122224,948225,769101,312102,864104,417105,96980,01980,79882,02285,48274,94275,97577,03878,10675,36774,28275,19912,259128,27913,566114,74314,988101,25016,62581,51818,35670,29519,37967,43421,07663,13420,31057,92717,65152,11118,64230,58010,05725,8367,57421,6898,76822,09410,00321,19111,23716,23512,47117,52213,70617,08113,19818,31018,91125,27717,50918,57611,45210,056
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
429,659
334,303
324,548
501,782
499,971
553,189
1,174,280
589,482
587,547
577,858
574,660
537,355
543,990
499,508
504,272
875,538
873,682
854,823
857,765
857,765854,823873,682875,538504,272499,508543,990537,355574,660577,858587,547589,4821,174,280553,189499,971501,782324,548334,303429,65900000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
10,838
17,229
36,783
17,699
15,852
28,379
43,389
26,374
24,726
23,421
28,446
29,870
33,819
35,411
30,268
36,525
25,155
34,709
38,083
39,070
44,261
25,905
38,200
36,422
40,029
36,751
49,706
57,214
58,860
37,222
50,305
73,395
78,151
50,517
59,497
67,201
74,350
105,170
82,047
80,862
69,014
123,089
113,318
105,395
116,802
137,923
138,863
128,252
119,846
148,402
152,771
135,738
130,397
151,191
157,156
153,694
196,156
285,671
282,177
280,375
276,791
469,732
453,699
441,530
448,931
403,757
376,308
394,564
398,989
410,094
409,788
424,497
411,231
434,234
409,031
408,727
426,129
396,602
406,528
394,145
374,879
374,879394,145406,528396,602426,129408,727409,031434,234411,231424,497409,788410,094398,989394,564376,308403,757448,931441,530453,699469,732276,791280,375282,177285,671196,156153,694157,156151,191130,397135,738152,771148,402119,846128,252138,863137,923116,802105,395113,318123,08969,01480,86282,047105,17074,35067,20159,49750,51778,15173,39550,30537,22258,86057,21449,70636,75140,02936,42238,20025,90544,26139,07038,08334,70925,15536,52530,26835,41133,81929,87028,44623,42124,72626,37443,38928,37915,85217,69936,78317,22910,838
   > Total Current Liabilities 
7,188
11,649
32,383
13,149
10,302
22,280
38,290
21,274
21,206
17,291
22,317
23,710
24,659
26,051
21,859
26,715
19,535
32,211
37,493
39,071
44,261
25,905
38,200
36,233
39,667
32,209
38,159
46,280
46,550
37,222
50,305
73,395
78,151
45,217
53,112
57,515
64,464
92,220
74,347
73,262
61,214
103,521
94,610
87,091
97,235
115,736
114,575
105,784
101,662
111,000
117,849
100,593
93,054
113,666
117,413
113,901
158,378
249,667
245,142
247,004
242,419
440,525
424,048
412,323
419,724
332,634
313,778
315,872
312,206
314,975
319,237
320,413
298,811
324,958
308,726
305,418
319,666
288,831
289,914
276,696
261,015
261,015276,696289,914288,831319,666305,418308,726324,958298,811320,413319,237314,975312,206315,872313,778332,634419,724412,323424,048440,525242,419247,004245,142249,667158,378113,901117,413113,66693,054100,593117,849111,000101,662105,784114,575115,73697,23587,09194,610103,52161,21473,26274,34792,22064,46457,51553,11245,21778,15173,39550,30537,22246,55046,28038,15932,20939,66736,23338,20025,90544,26139,07137,49332,21119,53526,71521,85926,05124,65923,71022,31717,29121,20621,27438,29022,28010,30213,14932,38311,6497,188
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
928
2,628
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002,628928000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
928
2,628
3,936
5,606
5,598
5,598
5,510
5,500
5,500
0
0
0
0
0
0
0
0
0
0000000005,5005,5005,5105,5985,5985,6063,9362,628928000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
233
5,145
4,443
3,505
3,827
19,305
16,904
12,669
9,079
8,378
13,622
9,687
10,098
14,433
7,886
12,149
7,235
14,563
14,982
14,570
16,407
11,560
13,635
12,155
11,952
11,760
6,187
5,829
5,839
8,051
10,437
10,799
10,343
9,600
9,791
11,952
14,057
27,056
26,543
22,629
18,687
36,462
31,820
23,901
29,413
42,669
34,138
41,282
39,861
39,827
48,256
47,725
40,862
30,914
42,154
40,084
49,988
111,501
102,823
79,860
81,482
264,946
265,916
266,799
269,278
178,506
186,459
175,324
183,882
179,927
182,779
189,035
183,081
191,400
188,677
186,014
183,371
176,179
173,179
176,290
168,242
168,242176,290173,179176,179183,371186,014188,677191,400183,081189,035182,779179,927183,882175,324186,459178,506269,278266,799265,916264,94681,48279,860102,823111,50149,98840,08442,15430,91440,86247,72548,25639,82739,86141,28234,13842,66929,41323,90131,82036,46218,68722,62926,54327,05614,05711,9529,7919,60010,34310,79910,4378,0515,8395,8296,18711,76011,95212,15513,63511,56016,40714,57014,98214,5637,23512,1497,88614,43310,0989,68713,6228,3789,07912,66916,90419,3053,8273,5054,4435,145233
       Other Current Liabilities 
5,455
6,504
8,730
9,644
6,475
2,975
21,386
8,605
12,127
8,913
8,695
14,023
14,561
11,618
13,973
14,566
12,300
17,648
22,511
24,501
27,854
14,345
24,565
24,078
27,715
20,449
31,972
40,451
40,711
29,171
39,868
62,596
67,808
35,617
43,321
45,563
50,407
65,164
47,804
50,633
42,527
67,059
62,791
63,191
67,823
71,293
80,437
63,573
61,801
69,838
69,593
52,868
52,191
82,751
75,259
73,816
108,390
138,166
142,318
122,985
150,036
130,048
100
100
100
120,473
98,730
111,213
108,074
104,304
113,640
98,694
96,711
101,513
97,443
91,431
112,764
2,109
90,512
70,677
64,891
64,89170,67790,5122,109112,76491,43197,443101,51396,71198,694113,640104,304108,074111,21398,730120,473100100100130,048150,036122,985142,318138,166108,39073,81675,25982,75152,19152,86869,59369,83861,80163,57380,43771,29367,82363,19162,79167,05942,52750,63347,80465,16450,40745,56343,32135,61767,80862,59639,86829,17140,71140,45131,97220,44927,71524,07824,56514,34527,85424,50122,51117,64812,30014,56613,97311,61814,56114,0238,6958,91312,1278,60521,3862,9756,4759,6448,7306,5045,455
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29,652
29,207
29,207
71,123
62,531
78,691
86,783
95,118
90,551
104,084
112,419
109,276
100,305
103,309
106,462
107,770
116,614
117,449
113,864
113,864117,449116,614107,770106,462103,309100,305109,276112,419104,08490,55195,11886,78378,69162,53171,12329,20729,20729,65200000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-928
-2,628
0
0
0
0
0
0
0
0
2,222
2,222
2,278
2,306
0
0
0
0
00002,3062,2782,2222,22200000000-2,628-928000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,466
0
0
0
4,466
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000004,4660004,46600000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160,683
167,246
191,216
214,166
203,046
212,462
233,749
236,573
248,207
249,389
291,838
308,839
340,893
408,128
394,723
402,825
413,051
439,050
0
424,164
483,642
436,428
436,428483,642424,1640439,050413,051402,825394,723408,128340,893308,839291,838249,389248,207236,573233,749212,462203,046214,166191,216167,246160,68300000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
66,292
85,607
114,950
129,713
351,233
361,357
353,961
363,058
375,328
381,876
390,918
394,192
408,276
425,565
448,326
470,389
512,384
551,272
587,352
637,589
703,505
760,409
808,057
831,761
905,883
965,513
1,021,958
1,050,250
1,112,600
1,190,752
1,255,646
1,463,862
1,545,151
1,623,979
1,726,280
1,857,329
1,909,885
2,040,118
2,152,175
2,238,724
2,407,338
2,565,664
2,733,562
2,923,640
2,993,686
3,147,944
3,344,158
3,497,474
3,479,672
3,577,848
3,722,883
3,824,594
3,804,064
3,896,513
4,025,684
4,131,291
4,137,447
4,270,639
4,449,900
4,275,832
4,460,235
4,497,847
4,717,807
4,857,837
4,786,682
4,808,197
4,918,283
5,002,060
4,912,103
4,974,607
5,088,700
5,272,522
5,303,227
5,311,498
5,373,741
5,375,677
5,448,271
5,468,082
5,670,012
5,682,511
5,682,915
5,682,9155,682,5115,670,0125,468,0825,448,2715,375,6775,373,7415,311,4985,303,2275,272,5225,088,7004,974,6074,912,1035,002,0604,918,2834,808,1974,786,6824,857,8374,717,8074,497,8474,460,2354,275,8324,449,9004,270,6394,137,4474,131,2914,025,6843,896,5133,804,0643,824,5943,722,8833,577,8483,479,6723,497,4743,344,1583,147,9442,993,6862,923,6402,733,5622,565,6642,407,3382,238,7242,152,1752,040,1181,909,8851,857,3291,726,2801,623,9791,545,1511,463,8621,255,6461,190,7521,112,6001,050,2501,021,958965,513905,883831,761808,057760,409703,505637,589587,352551,272512,384470,389448,326425,565408,276394,192390,918381,876375,328363,058353,961361,357351,233129,713114,95085,60766,292
   Common Stock
40,000
40,000
50,000
50,000
69,000
69,000
82,800
82,800
82,800
82,800
82,800
82,800
82,800
82,800
82,800
124,200
124,200
124,200
124,200
248,400
248,400
248,400
248,400
248,400
249,384
251,400
251,496
251,496
251,880
252,980
252,980
380,700
380,700
380,700
380,700
380,700
380,700
380,700
380,700
456,840
456,840
456,840
456,840
456,840
456,840
456,840
456,840
456,840
684,900
684,900
684,900
684,900
684,900
684,900
684,900
684,900
684,900
684,900
684,900
684,900
684,900
684,900
684,900
684,900
1,027,350
1,027,350
1,027,350
1,027,350
1,027,350
1,027,350
1,027,350
1,027,350
1,027,350
1,027,350
1,027,350
1,027,350
1,027,350
0
1,027,350
1,027,350
1,027,350
1,027,3501,027,3501,027,35001,027,3501,027,3501,027,3501,027,3501,027,3501,027,3501,027,3501,027,3501,027,3501,027,3501,027,3501,027,3501,027,350684,900684,900684,900684,900684,900684,900684,900684,900684,900684,900684,900684,900684,900684,900684,900684,900456,840456,840456,840456,840456,840456,840456,840456,840456,840380,700380,700380,700380,700380,700380,700380,700380,700252,980252,980251,880251,496251,496251,400249,384248,400248,400248,400248,400248,400124,200124,200124,200124,20082,80082,80082,80082,80082,80082,80082,80082,80082,80069,00069,00050,00050,00040,00040,000
   Retained Earnings 
21,309
37,709
50,235
63,596
73,096
77,452
70,055
79,152
91,422
92,399
101,441
104,715
118,799
129,442
147,876
165,413
205,396
236,357
270,722
320,171
384,299
426,003
472,727
495,457
566,685
602,144
658,307
686,599
747,896
803,972
879,130
994,099
1,084,361
1,118,534
1,216,788
1,341,503
1,391,831
1,478,777
1,580,903
1,599,173
1,748,109
1,826,645
2,242,616
2,431,059
2,513,317
2,677,120
2,856,209
3,056,221
2,806,481
2,877,661
3,026,756
3,131,214
3,100,234
3,192,789
3,319,890
3,425,553
3,446,439
3,589,384
3,771,747
3,597,112
3,778,886
3,818,384
3,491,939
3,629,715
3,227,981
3,782,107
3,886,022
3,978,887
3,879,873
3,941,345
4,054,552
4,242,888
4,274,551
4,264,550
4,326,084
4,327,142
4,399,763
3,763,808
4,598,148
4,610,648
4,611,052
4,611,0524,610,6484,598,1483,763,8084,399,7634,327,1424,326,0844,264,5504,274,5514,242,8884,054,5523,941,3453,879,8733,978,8873,886,0223,782,1073,227,9813,629,7153,491,9393,818,3843,778,8863,597,1123,771,7473,589,3843,446,4393,425,5533,319,8903,192,7893,100,2343,131,2143,026,7562,877,6612,806,4813,056,2212,856,2092,677,1202,513,3172,431,0592,242,6161,826,6451,748,1091,599,1731,580,9031,478,7771,391,8311,341,5031,216,7881,118,5341,084,361994,099879,130803,972747,896686,599658,307602,144566,685495,457472,727426,003384,299320,171270,722236,357205,396165,413147,876129,442118,799104,715101,44192,39991,42279,15270,05577,45273,09663,59650,23537,70921,309
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000-9,468-9,468-9,468-4000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-13,654
-11,025
-12,910
-12,029
-9,775
-21,646
-8,734
-2,564
-11,651
-2,594
-11,678
-10,792
-15,305
-16,264
-12,986
-12,277
-11,399
-11,426
0
667
667
667
6676676670-11,426-11,399-12,277-12,986-16,264-15,305-10,792-11,678-2,594-11,651-2,564-8,734-21,646-9,775-12,029-12,910-11,025-13,65400000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue999,824
Cost of Revenue-177,508
Gross Profit822,316822,316
 
Operating Income (+$)
Gross Profit822,316
Operating Expense-786,980
Operating Income212,84435,336
 
Operating Expense (+$)
Research Development165,847
Selling General Administrative344,508
Selling And Marketing Expenses-
Operating Expense786,980510,354
 
Net Interest Income (+$)
Interest Income22,420
Interest Expense--
Other Finance Cost-12,395
Net Interest Income10,025
 
Pretax Income (+$)
Operating Income212,844
Net Interest Income10,025
Other Non-Operating Income Expenses-
Income Before Tax (EBT)354,073212,844
EBIT - interestExpense = 0
314,024
314,024
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-354,073
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax354,073
Tax Provision-44,364
Net Income From Continuing Ops309,709309,709
Net Income314,024
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--10,025
 

Technical Analysis of Beijing SL Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Beijing SL Pharmaceutical Co Ltd. The general trend of Beijing SL Pharmaceutical Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Beijing SL Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Beijing SL Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.7 < 9.73 < 9.76.

The bearish price targets are: 7.05.

Tweet this
Beijing SL Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Beijing SL Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Beijing SL Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Beijing SL Pharmaceutical Co Ltd. The current macd is -0.13117991.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Beijing SL Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Beijing SL Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Beijing SL Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Beijing SL Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBeijing SL Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Beijing SL Pharmaceutical Co Ltd. The current adx is 24.24.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Beijing SL Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Beijing SL Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Beijing SL Pharmaceutical Co Ltd. The current sar is 7.852944.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Beijing SL Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Beijing SL Pharmaceutical Co Ltd. The current rsi is 51.29. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Beijing SL Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartBeijing SL Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Beijing SL Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Beijing SL Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Beijing SL Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartBeijing SL Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Beijing SL Pharmaceutical Co Ltd. The current cci is 39.04.

Beijing SL Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartBeijing SL Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Beijing SL Pharmaceutical Co Ltd. The current cmo is 12.23.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Beijing SL Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartBeijing SL Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Beijing SL Pharmaceutical Co Ltd. The current willr is -5.81395349.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Beijing SL Pharmaceutical Co Ltd Daily Williams %R ChartBeijing SL Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Beijing SL Pharmaceutical Co Ltd.

Beijing SL Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Beijing SL Pharmaceutical Co Ltd. The current atr is 0.27356079.

Beijing SL Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartBeijing SL Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Beijing SL Pharmaceutical Co Ltd. The current obv is 1,287,351,389.

Beijing SL Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartBeijing SL Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Beijing SL Pharmaceutical Co Ltd. The current mfi is 56.70.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Beijing SL Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartBeijing SL Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Beijing SL Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Beijing SL Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Beijing SL Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.293
Ma 20Greater thanMa 508.481
Ma 50Greater thanMa 1008.853
Ma 100Greater thanMa 2009.293
OpenGreater thanClose8.610
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Beijing SL Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Beijing SL Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Beijing SL Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Beijing SL Pharmaceutical Co Ltd

I send you an email if I find something interesting about Beijing SL Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Beijing SL Pharmaceutical Co Ltd.

Receive notifications about Beijing SL Pharmaceutical Co Ltd in your mailbox!